Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals - A lesser benefit in females

European Respiratory Journal

Volumn 15, Issue 1, 2000, Pages 19-24

  Convery, R P ^a   Leitch, D N ^a   Bromly, C ^a   Ward, R J ^a   Bartlett, G ^b   Hendrick, D J ^a,b,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Airway responsiveness; Asthma; Corticosteroids; Fluticasone; Sex; Smoking

Indexed keywords

FLUTICASONE PROPIONATE; METHACHOLINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CHEMOPROPHYLAXIS; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; NORMAL HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ADULT; AIRWAY RESISTANCE; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TREATMENT OUTCOME;

EID: 0033959574     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15a05.x     Document Type: Article

References (27)

1. Devereux G, Ayatollahi T, Ward R, et al. Airway responsiveness, asthma, and air pollution in two contrasting districts of northern England. Thorax 1996; 51: 169-174.
2. Meibohm B, Mollmann H, Wagner M, Hochhaus G, Mollman A, Derendorf H. The clinical pharmacology of fluticasone propionate. Rev Contemp Pharmacother 1998; 9: 535-549.
3. Weiss ST, Gold DR. Guest editorial: gender differences in asthma. Pediatr Pulmonol 1995; 19: 153-155.
4. Gerritsen J, Koeter G, Postma D, Schouten J, Knol K. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 1989; 140: 1325-1330.
5. Withers NJ, Low L, Holgate ST, Clough JB. The natural history of respiratory symptoms in a cohort of adolescents. Am J Respir Crit Care Med 1998; 158: 352-357.
6. Strachen DP, Cook DG. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case control studies. Thorax 1998; 53: 204-212.
7. Beach JR, Young CL, Avery AJ, et al. Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax 1993; 48: 239-243.
8. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vessey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77: 1435-1438.
9. Stenton SC, Dennis JH, Walters EH, Hendrick DJ. The asthmagenic properties of a newly developed detergent ingredient - sodium iso-nonanoyl oxybenzene sulphonate. Br J Industr Med 1990; 47: 405-410.
10. Convery RP, Ward RJ, Hendrick DJ. Occupational asthma due to a widely used soft solder flux not containing colophony. Eur Respir J 1997; 10: 238-240.
11. Aiken TC, Ward RJ, Peel ET, Hendrick DJ. Occupational asthma due to porcine pancreatic amylase. Occup Environ Med 1997; 54: 762-764.
12. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine. Am Rev Respir Dis 1987; 136: 1412-1417.
13. Olivieri D, Chetta A, del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodelling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155: 1864-1871.
14. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Treatment with inhaled budesonide in patients with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340: 1948-1953.
15. Togias A, Horowitz E, Joyner D, Guydon L, Malveaux F. Evaluating the factors that relate to asthma severity in adolescents. Int Arch Allergy Immunol 1997; 113: 87-95.
16. Sunyer J, Anó JM, Kogevinas M, et al. Risk factors for asthma in young adults. Eur Respir J 1997; 10: 2490-2494.
17. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. 1. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994; 149: 371-375.
18. Skobeloff EM, Spivey WH, St Clair SS, Schoffstall JM. The influence of age and sex on asthma admissions. JAMA 1992; 268: 3437-3440.
19. Otopade CO, Alikakos Z, Abubaker J, Rubinstein IR. Characteristics of predominantly nonwhite patients with frequent hospitalizations for acute asthma in Chicago. J Asthma 1997; 34: 243-248.
20. Stempl DA, Hedblom C, Durcanin-Robbins JF, Sturm LL. Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditure. Arch Fam Med 1996; 36: 36-40.
21. Prescott E, Lange P, Vestbo J. Effect of gender on hospital admissions for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Thorax 1997; 52: 287-289.
22. Osborne ML, Vollmer WM, Linton KLP, Buist AS. Characteristics of patients with asthma within a large HMO. Am J Respir Crit Care Med 1998; 157: 123-128.
23. Devereux G, Hendrick DJ, Stenton SC. Perception of respiratory symptoms after methacholine-induced bronchoconstriction in a general population. Eur Respir J 1998; 12: 1089-1093.
24. Lin RY, Rehman A. Clinical characteristics of adult asthmatics requiring intubation. J Med 1995; 26: 261-277.
25. Tough SC, Green FH, Paul JE, Wigle DT, Butt JC. Sudden death from asthma in 108 children and young adults. J Asthma 1996; 33: 179-188.
26. Roberts C, Mayer JD, Henderson WR. Asthma deaths in Washington State, 1980-1989 geographic and demographic distributions. Ann Allergy Asthma Immunol 1996; 76: 20-26.
27. Reid DWEC, Hendrick VJ, Aiken TC, Berrill WT, Stenton SC, Hendrick DJ. Age-dependent inaccuracy of asthma death certification in Northern England, 1991-1992. Eur Respir J 1998; 12: 1079-1083.